To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions

NCT04155203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

657

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondarily Infected Traumatic Skin Lesions

Interventions

DRUG: Mupirocin Calcium
DRUG: Mupirocin Calcium
DRUG: Vehicle

Sponsor

Padagis LLC